MARKET

ABEO

ABEO

Abeona Therapeut
NASDAQ
2.455
-0.085
-3.35%
Closed 19:58 11/10 EST
OPEN
2.640
PREV CLOSE
2.540
HIGH
2.660
LOW
2.390
VOLUME
3.64M
TURNOVER
1.64M
52 WEEK HIGH
7.65
52 WEEK LOW
2.300
MARKET CAP
140.39M
P/E (TTM)
-2.2135
1D
5D
1M
3M
1Y
5Y
1D
Abeona Therapeutics price target lowered to $7.50 from $17 at Roth Capital
TipRanks · 21h ago
Oppenheimer Sticks to Their Buy Rating for Abeona Therapeutics (ABEO)
TipRanks · 1d ago
Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 1d ago
Abeona Therapeutics Price Target Cut to $19.00/Share From $30.00 by Cantor Fitzgerald
Dow Jones · 1d ago
Abeona Therapeutics (ABEO) Q3 2026 Earnings Call Transcript
The Motley Fool · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 1d ago
Abeona Therapeutics Acquires Late-Stage Drug Candidate, Secures $30 Million in Equity Financing
Benzinga · 1d ago
Abeona Therapeutics Reports Q3 Net ZEVASKYN Revenue of $13.5 million and Acquisition of ABO-801
NASDAQ · 1d ago
More
About ABEO
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company building a portfolio of therapies for rare and serious diseases. The Company's portfolio includes ZEVASKYN (prademagene zamikeracel), the autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB); ABO-801, a Phase III-ready product candidate for eosinophilic esophagitis (EoE); and ABO-701 (PSMA-SIR-T), an investigational engineered T-cell therapy targeting Prostate-Specific Membrane Antigen (PSMA). ZEVASKYN is a type of gene therapy made from a patient's own skin cells that is surgically applied to treat wounds in both children and adults who have RDEB. The Company's fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. ABO-801 is a once-daily oral disintegrating tablet formulation of fluticasone propionate.

Webull offers Abeona Therapeutics Inc stock information, including NASDAQ: ABEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABEO stock methods without spending real money on the virtual paper trading platform.